Allogene Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Allogene Therapeutics by Summit Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $36k | 13k | 2.80 |
2024-06-30 | $19k | 8.1k | 2.33 |
2024-03-31 | $36k | 8.1k | 4.47 |
2023-12-31 | $26k | 8.1k | 3.21 |
2023-09-30 | $26k | 8.1k | 3.17 |
2023-06-30 | $30k | 6.0k | 4.97 |
2023-03-31 | $30k | 6.0k | 4.94 |
2022-12-31 | $41k | 6.0k | 6.86 |
2022-09-30 | $65k | 6.0k | 10.77 |
2022-06-30 | $68k | 6.0k | 11.26 |
2022-03-31 | $49k | 5.3k | 9.19 |
2021-12-31 | $80k | 5.3k | 15.00 |
2021-09-30 | $137k | 5.3k | 25.69 |
2021-06-30 | $139k | 5.3k | 26.07 |
2021-03-31 | $162k | 4.6k | 35.26 |
2020-12-31 | $116k | 4.6k | 25.25 |
2020-09-30 | $173k | 4.6k | 37.66 |
2020-06-30 | $183k | 4.3k | 42.71 |
2020-03-31 | $65k | 3.4k | 19.40 |
2019-12-31 | $87k | 3.4k | 25.96 |
2019-09-30 | $91k | 3.4k | 27.16 |
2019-06-30 | $90k | 3.4k | 26.86 |
2019-03-31 | $51k | 1.8k | 28.93 |
2018-12-31 | $47k | 1.8k | 26.66 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors